On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayApr 05, 2017 10:38 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Subsidiary Adds Apple Pay Support in Russia

Mobile payment technology company Net Element, Inc. (NASDAQ: NETE), through its PayOnline subsidiary, this morning announced the launch of Apple Pay support for its Russian markets. “As the shift to mobile payments continues, PayOnline delivers the necessary support and tools merchants need to make payments a seamless part of online and mobile purchases,” Marat Abasaliev, head of online solutions for PayOnline, stated in the news release. “By delivering support to merchants that use Apple Pay, PayOnline demonstrates its ability to meet the growing demand for secure, convenient and quick transactions.” According to data from Apple, the global number of Apple…

Continue Reading

WednesdayApr 05, 2017 10:11 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Announces Sale of Brilliant Hallmark Stake

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the sale of its investment interest in Brilliant Hallmark for a consideration of four million shares of IGC. The shares, which were previously issued to Brilliant Hallmark on August 4, 2016, will be returned and retired, while the Brilliant Hallmark investment will be removed from the company's balance sheet with an associated reduction of roughly $1.88 million. Per this morning’s update, IGC does not expect to record a gain or loss from this transaction. “This strategic move is…

Continue Reading

TuesdayApr 04, 2017 3:52 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 4, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: BNTC 61.49% – News: Pre-clinical efficacy results published in Nature Communications SHIP 23.72% – News: Enters agreement to acquire a modern Capesize vessel ONTX 13.29% – News: Presents data at the 2017 AACR Annual Meeting ACLZ 9.00% – News: Names new VP of sales EARK 4.21% – News: Magnolia Solar subsidiary awarded a new U.S. patent TGEN 2.71% – News: Presenting as SAE World Congress on April 4 EMMD 1.85% – News: Acquires TravelsHunter.com…

Continue Reading

TuesdayApr 04, 2017 3:50 pm

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (IMLFF) Takes Aim at Rare Skin Diseases with INM-750

Epidermolysis bullosa (EBS) is a group of rare inherited skin diseases that unfortunately have no currently approved or known cure or treatment. InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has developed INM-750 as the first therapy to specifically treat EBS. “Earlier this month, InMed filed an international Patent Cooperation Treaty application for intellectual and commercial protection of INM-750 and a cannabinoid-based therapy for EBS. This marks a significant milestone for the company, serving as validation for its efforts to develop new therapies based on cannabinoids and its unique approach to drug development. The company is using a proprietary bioinformatics assessment tool to…

Continue Reading

TuesdayApr 04, 2017 3:49 pm

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Advances PRO 140 to Provide a Better Quality of Life for HIV Patients

More than 34 million people have died from HIV since it was first discovered in 1981, according to Healthline (http://nnw.fm/i9ptS). Although there is no known cure for the disease, CytoDyn Inc. (OTCQB: CYDY) is advancing its drug candidate toward providing a better life for HIV patients. “PRO 140 is currently one of the most advanced experimental monoclonal antibodies for HIV treatment, and CYDY believes that it will be beneficial to patients with complicating issues, such as those with single or multi-drug resistant viruses or those who have difficulty sticking to a daily drug regimen, as well as those who can’t…

Continue Reading

TuesdayApr 04, 2017 3:48 pm

NetworkNewsBreaks – ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) Results from New Studies Match Previous Findings, CRV431 Targets Hepatitis B Surface Antigen (HBsAg)

ContraVir Pharmaceuticals (NASDAQ: CTRV) this morning released results from new studies that provide insight into the mechanism of action (MOA) of its hepatitis B virus CRV431. The new studies show that CRV431 potently blocks the interaction between hepatitis B surface antigen (HBsAg), a key HBV protein, and cyclophilin A, an important cellular protein. The new information could explain previous findings that the drug reduces HBsAg. High levels of HBsAg in HBV-infected patients is a predictor for progression of disease, including liver fibrosis, cirrhosis, and cancer. “Our finding that CRV431 targets hepatitis B surface antigen is promising because reducing or eradicating…

Continue Reading

TuesdayApr 04, 2017 11:19 am

NetworkNewsBreaks – Evoke Pharma (NASDAQ: EVOK) Moves Forward with Comparative Exposure PK Trial for Gimoti NDA Following Type A Meeting with FDA

Evoke Pharma (NASDAQ: EVOK) shares rallied as much as 11% this morning after the company provided details of its positive Type A meeting with the U.S. Food and Drug Administration (FDA). Evoke met with the FDA to finalize the design of the pivotal comparative exposure pharmacokinetic (PK) trial and to reach agreement on additional aspects of the Chemistry, Manufacturing & Controls (CMC) section of the New Drug Application (NDA) for Gimoti™ for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adult women. The pivotal comparative exposure PK trial will be conducted in healthy volunteers to demonstrate…

Continue Reading

TuesdayApr 04, 2017 11:17 am

NetworkNewsBreaks – Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) Receives Patent for TSC in Five Hypoxia-Related Indications; Shares Rally

Shares of Diffusion Pharmaceuticals (NASDAQ: DFFN) surged as much as 23% this morning after the company announced that the U.S. Patent and Trademark Office (USPTO) has issued a key patent for the company’s lead drug candidate, trans sodium crocetinate (TSC). Diffusion’s existing patents currently include the use of TSC in oncology, stroke and neurodegenerative disease indications. The new patent increases coverage of the therapeutic use of TSC and other related compounds to five hypoxia-related conditions including congestive heart failure, chronic renal failure, acute lung injury, chronic obstructive pulmonary disease, and respiratory distress syndrome. “Receiving the patent from the USPTO validates…

Continue Reading

TuesdayApr 04, 2017 9:42 am

NetworkNewsBreaks – Bollente Companies, Inc. (BOLC) Announces Selection of trutankless® as Exclusive Water Heating Solution of Cullum Homes

Bollente Companies, Inc. (OTCQB: BOLC) this morning announced that its innovative trutankless® line of smart electric tankless water heaters has been selected as the exclusive water heating solution for luxury communities constructed by award-winning Arizona home builder Cullum Homes. “trutankless is the only whole-home water heating solution I recommend,” Rod Cullum, owner and founder of Cullum Homes, stated in the news release. “I have used trutankless for years in my own home, where my family and I enjoy reliable, endless hot water. It only makes sense that I would offer the same quality and energy-efficient technology in the homes I…

Continue Reading

MondayApr 03, 2017 1:43 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 3, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: KPAY 29.44% – News: Moves on momentum from recent launch of “No Administration Fee” campaign for Perusahaan Listrik Negara YTEN 14.10% – News: Presenting live at VirtualInvestorConferences.com on April 6 GRWG 13.68% – News: Posts FY 2016 financial results EBIO 12.27% – News: Presents new preclinical data with VB4-845 at AACR Annual Meeting 2017 NBEV 10.90% – News: Posts FY 2016 financial results, reports multiple new acquisitions ESDI 10.27% – News: Posts FY 2016…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217